Neutrophils recruitment during sepsis: Critical points and crossroads

Frontiers in Bioscience

Volumn 14, Issue 12, 2009, Pages 4464-4476

  Da Silva, Fabiano Pinheiro ^a   Soriano, Francisco Garcia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adhesion; Fc receptors; ICAM; Neutrophil; Nitric oxide; PARP; Review; Sepsis; VCAM

Indexed keywords

BACTERIA (MICROORGANISMS);

FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

CELL ADHESION; CYTOLOGY; ENDOTHELIUM; ENZYME ACTIVATION; HUMAN; METABOLISM; NEUTROPHIL; PATHOLOGY; REVIEW; SEPSIS;

CELL ADHESION; ENDOTHELIUM; ENZYME ACTIVATION; FREE RADICALS; HUMANS; NEUTROPHILS; POLY(ADP-RIBOSE) POLYMERASES; SEPSIS;

EID: 63849124027     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3542     Document Type: Article

References (77)

1. Hotchkiss, R. S. and I. E. Karl. The pathophysiology and treatment of sepsis. N Engl J Med 348, 138-150(2003) (Pubitemid 36056721)
2. Bone, R. C., and C. J. Fisher, Jr. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317, 653-658(1987) (Pubitemid 17138189)
3. Greenman, R. L., R. M. Schein, M. A. Martin, R. P. Wenzel, N. R. MacIntyre, G. Emmanuel, H. Chmel, R. B. Kohler, M. McCarthy, and J. Plouffe. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. Jama 266, 1097-1102(1991)
4. Ziegler, E. J., C. J. Fisher, Jr. Treatment of gramnegative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 324, 429-436(1991)
5. Dhainaut, J. F., and A. Tenaillon. Plateletactivating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, doubleblind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med 22, 1720-1928(1994)
6. Fisher, C. J., Jr., J. F. Dhainaut, S. M. Opal, J. P. Pribble, R. A. Balk, G. J. Slotman, T. J. Iberti, E. C. Rackow, M. J. Shapiro, and R. L. Greenman. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebocontrolled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. Jama 271, 1836-1843(1994) (Pubitemid 24169697)
7. Abraham, E., R. Wunderink, H. Silverman, T. M. Perl, S. Nasraway, H. Levy, R. Bone, R. P. Wenzel, R. Balk, and R. Allred. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. Jama 273, 934-41(1995)
8. Bone, R. C., and R. A. Balk. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med 23, 994-1006(1995)
9. Zeni, F., and B. Freeman. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25, 1095-1100(1997) (Pubitemid 27310241)
10. Bone, R. C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24, 163-172(1996)
11. Bone, R. C., C. J. Grodzin, and Robert A. Balk. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112, 235-243(1997) (Pubitemid 27343624)
12. Nathan, C. Points of control in inflammation. Nature 420, 846-852(2002) (Pubitemid 36019637)
13. Russell, J. A. Management of sepsis. N Engl J Med 355, 1699-1713(2006) (Pubitemid 44583960)
14. Hornef, M. W., M. J. Wick, Rhen M. and Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 3, 1033-1040(2002) (Pubitemid 35363654)
15. Theilgaard-Monch, K., B. T. Porse, and S. Knudsen. Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol 18, 54-60(2006) (Pubitemid 43049648)
16. Theilgaard-Monch, K., S. Knudsen, and B. T. Porse. 2004. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 172, 7684-7693(2004) (Pubitemid 38747635)
17. Yonekawa, K. and J. M. Harlan. Targeting leukocyte integrins in human diseases. J Leukoc Biol 77, 129-140(2005) (Pubitemid 40315046)
18. Korthuis, R. J., D. C. Anderson and D. N. Granger. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care 9, 47-71(1994) (Pubitemid 24095050)
19. Panes, J., M. Perry, and D. N. Granger. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol 126, 537-550(1999) (Pubitemid 29087827)
20. McEver, R. P. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 14, 581-586(2002) (Pubitemid 35247741)
21. Carlos, T. M. and J. M. Harlan. Leukocyteendothelial adhesion molecules. Blood 84, 2068-2101(1994)
22. Kunkel, E. J., U. Jung, D. C. Bullard, K. E. Norman, B. A. Wolitzky, D. Vestweber, A. L. Beaudet and K. Ley. Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1. J Exp Med 183, 57-65(1996)
23. Mayadas, T. N., R. C. Johnson, H. Rayburn, R. O. Hynes, and D. D. Wagner. Leukocyte rolling and extravasation are severely compromised in P selectindeficient mice. Cell 74, 541-554(1993) (Pubitemid 23244619)
24. Bullard, D. C., E. J. Kunkel, H. Kubo, M. J. Hicks, I. Lorenzo, N. A. Doyle, C. M. Doerschuk, K. Ley and A. L. Beaudet. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med 183, 2329-2336(1996) (Pubitemid 26158923)
25. Xia, L., and M. Sperandio, T. Yago, J. M. McDaniel, R. D. Cummings, S. Pearson-White, K. Ley, and Rodger P. McEver. P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest 109, 939-950(2002) (Pubitemid 34275115)
26. Bargatze, R. F., S. Kurk, E. C. Butcher and M. A. Jutila. Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J Exp Med 180, 1785-1792(1994) (Pubitemid 24328569)
27. Rosen, S. D. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22, 129-156(2004) (Pubitemid 38680420)
28. Danen, E. H. and A. Sonnenberg. Integrins in regulation of tissue development and function. J Pathol 201, 632-641(2003)
29. Panes, J. and D. N. Granger. Leukocyteendothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114, 1066-1090(1998) (Pubitemid 28217575)
30. Ley, K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 186, 8-18(2002)
31. Smith, C. W., S. D. Marlin, R. Rothlein, C. Toman and D. C. Anderson. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83, 2008-2017(1989) (Pubitemid 19148873)
32. Furie, M. B., and M. C. Tancinco. Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 78, 2089-2097(1991)
33. Mayadas, T. N. and X. Cullere. 2005. Neutrophil beta2 integrins: moderators of life or death decisions. Trends Immunol 26, 388-395(2005) (Pubitemid 40835845)
34. Etzioni, A., and M. Frydman. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327, 1789-1792(1992)
35. McEwen, B. S. Protective and damaging effects of stress mediators. N Engl J Med 338, 171-179(1998)
36. Viswanathan, K. and F. S. Dhabhar. Stressinduced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc Natl Acad Sci U S A 102, 5808-5813(2005) (Pubitemid 40559641)
37. Zlotnik, A. and O. Yoshie. Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127(2000) (Pubitemid 30398626)
38. Wilson, M., and R. Seymour. Bacterial perturbation of cytokine networks. Infect Immun 66, 2401-2409(1998) (Pubitemid 28261731)
39. Simon, S. I. and C. E. Green. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 7, 151-185(2005) (Pubitemid 41170187)
40. Takeda, K., T. Kaisho, and S. Akira. Toll-like receptors. Annu Rev Immunol 21, 335-376(2003) (Pubitemid 37174535)
41. Parker, L. C., and M. K. Whyte. The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol 77, 886-892(2005) (Pubitemid 40770839)
42. Pugin, J., R. J. Ulevitch, and PS Tobias. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med 178, 2193-2200(1993) (Pubitemid 23344877)
43. Ali, H., and R. M. Richardson. Chemoattractant receptor cross-desensitization. J Biol Chem 274, 6027-6030(1999) (Pubitemid 29111002)
44. Lotz, S., E. Aga, G. van Zandbergen, T. Hartung, W. Solbach and T. Laskay. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leukoc Biol 75, 467-477(2004) (Pubitemid 38316378)
45. Sabroe, I., and L. R. Prince, S. K. Dower, S. R. Walmsley, E. R. Chilvers and M. K. B. Whyte. What can we learn from highly purified neutrophils? Biochem Soc Trans 32, 468-469(2004) (Pubitemid 38813539)
46. Choi, K. B., Choi, K. B., F. Wong, J. M. Harlan, P. M. Chaudhary, L. Hood, and A. Karsan. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J Biol Chem 273, 20185-20188(1998) (Pubitemid 28377578)
47. Daeron, M. Fc receptor biology. Annu Rev Immunol 15, 203-234(1997) (Pubitemid 27169280)
48. Ravetch, J. V. and S. Bolland. IgG Fc receptors. Annu Rev Immunol 19:275-290(2001) (Pubitemid 32368037)
49. Billadeau, D. D. and P. J. Leibson. ITAMs versus ITIMs: striking a balance during cell regulation. J Clin Invest 109, 161-168(2002) (Pubitemid 34083734)
50. Daha, M. R., A. M. Miltenburg, P. S. Hiemstra, N. Klar-Mohamad, L. A. Van Es, and V. W. M. Van Hinsbergh. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro. Eur J Immunol 18, 783-787(1988)
51. Mayadas, T. N., and A. Rosenkranz. Glomerular inflammation: use of genetically deficient mice to elucidate the roles of leukocyte adhesion molecules and Fc-gamma receptors in vivo. Curr Opin Nephrol Hypertens 8, 293-298(1999) (Pubitemid 29381617)
52. Stokol, T., P. O'Donnell, L. Xiao, S. Knight, G. Stavrakis, M. Botto, U. H. von Andrian, and T. N. Mayadas. C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment. J Exp Med 200, 835-846(2004) (Pubitemid 39362920)
53. Mocsai, A., C. L. Abram, Z. Jakus, Y. Hu, L. L. Lanier and C. A. Lowell. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat Immunol 7, 1326-1333(2006) (Pubitemid 46111254)
54. Li, J. M. and A. M. Shah. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287, R1014-R1030 (2004) (Pubitemid 39391043)
55. Englert, R. P. and Shacter, E. Distinct Modes of Cell Death Induced by Different Reactive Oxygen Species-Amino acylchloramines mediate hypochlorous acid-induced apoptosis. JBC 277, 20518-20519(2002)
56. Soriano, F. G., L. Virag, and C Szabo. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADP-ribose) polymerase activation. J Mol Med 79, 437-448(2001) (Pubitemid 32757469)
57. Schreiber, V., D. Hunting, C Trucco, B Gowans, D Grunwald, G De Murcia, and J M De Murcia. A dominant-negative mutant of human poly (ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage. Proc Natl Acad Sci U S A 92, 4753-4757(1995)
58. Soriano, F. G., P. Pacher, J. Mabley L. Liaudet, and C. Szabo. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP-ribose) polymerase. Circ Res 89, 684-691(2001) (Pubitemid 34627068)
59. Kim, H., and M. K. Jacobson. Photoaffinity labelling of human poly (ADP-ribose) polymerase catalytic domain. Biochem J 322, 469-475(1997) (Pubitemid 27116572)
60. Nicotera, P., and M. Leist. Execution of apoptosis: converging or diverging pathways? Biol Chem 380, 1035-1040(1999) (Pubitemid 29484026)
61. Nicotera, P., and M. Leist. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 102, 139-142(1998) (Pubitemid 29021213)
62. Garcia Soriano, F., L. Virag, L. Murthy, A Marton, A Salzman, P Jagtap, L. Liaudet, and C. Szabo. Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat Med 7, 108-113(2001) (Pubitemid 32095649)
63. Jijon, H. B., T. Churchill. Inhibition of poly (ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 279, G641-G651 (2000)
64. Tewari, M., and L. T. Quanl. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81:801-809(1995)
65. Germain, M., and E. B. Affar. Cleavage of automodified poly (ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 274, 28379-28384(1999)
66. Lazebnik, Y. A., and S. H. Kaufmann. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347(1994) (Pubitemid 24300618)
67. Kim, J. W., and K. Kim. Inhibition of homodimerization of poly (ADP-ribose) polymerase by its C-terminal cleavage products produced during apoptosis. J Biol Chem 275, 8121-8125(2000) (Pubitemid 30159726)
68. Herceg, Z. and Z. Q. Wang. Failure of poly (ADP-ribose) polymerase cleavage by caspases leads to induction o necrosis and enhanced apoptosis. Mol Cell Biol 19, 5124-5133(1999) (Pubitemid 29289550)
69. Yu, S. W., and H. Wang. Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259-263(2002) (Pubitemid 34761289)
70. Anderson, HA, and R. Englert. Oxidative stress inhibits the phagocytosis of apoptotic cells that have externalized phosphatidylserine. Cell Death and Differentiation 9, 616-625(2002) (Pubitemid 34618867)
71. Marini, M., and F. Frabetti. Inhibition of poly (ADP-ribose) polymerization preserves the glutathione pool and reverses cytotoxicity in hydrogen peroxide-treated lymphocytes. Biochem Pharmacol 46, 2139-2144(1993) (Pubitemid 24012304)
72. Szabo, C., and G. Ferrer-Sueta. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 272, 9030-9036(1997) (Pubitemid 27154903)
73. Szabo, C., and B. Zingarelli. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78, 1051-1063(1996) (Pubitemid 26168580)
74. Villa, L. M., and E. Salas, V M Darley-Usmar, M W Radomski, and S Moncada. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci U S A 91, 12383-12387(1994)
75. Liaudet, L., F. G. Soriano, L Virag, E Szabo, and C Szabo. Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase. Proc Natl Acad Sci U S A 97, - 10208 (2000)
76. Kuhnle, S., and P. Nicotera, A. Wendel and M. Leist. Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly (ADP-ribose) polymerase-deficient mice. Biochem Biophys Res Commun 263, 433-438(1999) (Pubitemid 29467214)
77. Oliver, F. J., J. Menissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohaina, S. Muller, G. de la Rubia, J. C. Stoclet and G. de Murcia. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. Embo J 18, 4446-4454(1999) (Pubitemid 29391254)